Novel immunosuppression in pancreas transplantation and outcomes

Current Opinion in Organ Transplantation

Volumn 12, Issue 1, 2007, Pages 77-81

  Axelrod, David ^a,c   Kaufman, Dixon B ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

DCD; Induction therapy; Pancreas transplantation; Steroid free

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; DACLIZUMAB; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RABBIT ANTITHYMOCYTE GLOBULIN; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

CADAVER DONOR; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEART DEATH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY PANCREAS TRANSPLANTATION; NEPHROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGAN DONOR; OSTEOLYSIS; PANCREAS TRANSPLANTATION; RECIPIENT; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33846314343     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328012e3b8     Document Type: Review

References (18)

1. Cohen DS, Martin L, Christensen LL, et al. Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006; 6:1153-1169. This is a comprehensive review of patients transplanted in the United States.
2. Venstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290:2817-2823.
3. Gruesssner RWG, Sutherland DER, Gruessner AW. Mortality assessment in pancreas transplants. Am J Transplant 2004; 4:2017-2023.
4. Gruessner AC, Sutherland DER. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19:433-455. This is a comprehensive review of the international experience with pancreas transplantation trends and outcomes.
5. Stratta RJ, Alloway RR, Lo A, Hodge E. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study. Transplantation 2003; 75:1260-1266.
6. Burke GW 3rd, Kaufman DB, Millis JM, et al. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation 2004; 77:1269-1275.
7. Kaufman DB, Leventhal JR, Koffron AJ, et al. A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/ mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002; 73:169-177.
8. Cantarovich D, Giral-Classe M, Hourmant M, et al. Low Incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective study in 28 consecutive cases. Transplantation 2000; 69:1505-1508.
9. Cantarovich D, Karam G, Hourmant M, et al. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 2005; 5:1332-1338. This is a report of the initial experience with complete steroid avoidance in SPK transplantation.
10. Kaufman DB, Leventhal JR, Gallon LG, Parker MA. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction: long-term results. Am J Transplant 2006; 6:331-339. This large single institutional study evaluated two induction regimens.
11. Kaufman DB, Leventhal JR, Parker MA, Gallon L. Alemtuzumab induction and prednisone free immunosuppression in solitary pancreas transplantation [abstract]. Am J Transplant 2006; 6 (Suppl 2):221.
12. Fridell JA, Agarwal A, Powelson JA, et al. Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. Transplantation 2006; 82:389-392.
13. Kaufman DB, Leventhal JR, Parker MA, Gallon L. Calcineurin inhibitor-free/ rapid steroid elimination immunosuppression in simultaneous pancreas-kidney transplantation [abstract]. Am J Transplant 2006; 6 (Suppl 2):104.
14. Gruessner RW, Kandaswamy R, Humar A, et al. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation 2005; 79:1184-1189. This is the initial report of steroid free calcineurin inhibitor-free immunosuppression in pancreas transplantation.
15. Fernandez LA, Di Carlo A, Odorico JS, et al. Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg 2005; 242:716-723. This describes the largest single center series of pancreas transplants from DCD donors.
16. Salvalaggio PR, Davies DB, Fernandez LA, Kaufman DB. Outcomes of pancreas transplantation in the United States using cardiac-death donors. Am J Transplant 2006; 6 (5 Pt 1):1059-1065. The authors present national experience with pancreas transplantation using DCD donors.
17. Johnson SR, Pavlakis M, Khwaja K, et al. Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death. Transplantation 2005; 80:1244-1250.
18. Demartines N, Schiesser M, Clavien PA. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant 2005; 5:2688-2697.